Zobrazeno 1 - 10
of 596
pro vyhledávání: '"David, Henderson"'
Autor:
Kieran D Sweeney, Eddie Donaghy, David Henderson, Harry HX Wang, Andrew Thompson, Bruce Guthrie, Stewart W Mercer
Publikováno v:
BJGP Open, Vol 8, Iss 3 (2024)
Background: Expanding primary care multidisciplinary teams (MDTs) was a key component of the 2018 Scottish GP contract, with more than 4700 MDT staff appointed since then. Aim: To explore patients’ views on primary care MDT expansion in Scotland. D
Externí odkaz:
https://doaj.org/article/3be7b9d2141a47699aa317e3537631d6
Publikováno v:
Health Science Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background and Aims Although previous studies on mental health/illness in Nigeria have explored knowledge and attitude of community members using quantitative approaches, few studies have engaged stakeholders within rural communities on the
Externí odkaz:
https://doaj.org/article/256b3a2d49a04c0e883246109d0b9f9b
Autor:
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet Markman, Magdalena Nauerth, Helene Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Lymphodepletion (LD) or conditioning is an essential step in the application of currently used autologous and allogeneic chimeric antigen receptor T-cell (CAR-T) therapies as it maximizes engraftment, efficacy and long-term survival of CAR-T. Its mai
Externí odkaz:
https://doaj.org/article/867d97eccd50488c8737f46f9637a5f0
Publikováno v:
International Journal on Homelessness, Vol 3, Iss 2, Pp 344-410 (2023)
Homelessness prevention for single adults at risk of or experiencing multiple exclusion homelessness (MEH) has received limited attention in research. This systematic review focused on the effectiveness of primary, secondary, and tertiary homelessnes
Externí odkaz:
https://doaj.org/article/29628b0d426f49858595cd50ddc5e0ea
Autor:
Sandra Kendzia, Susanne Franke, Tarek Kröhler, Nicole Golob-Schwarzl, Caroline Schweiger, Anna M. Toeglhofer, Christina Skofler, Stefan Uranitsch, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Marie-Laure Yaspo, Christoph Reinhard, Reinhold Schäfer, Ulrich Keilholz, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd F. Lax, Frank Erdmann, Marcel H. Schulz, Alexandra K. Kiemer, Johannes Haybaeck, Sonja M. Kessler
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Aim Chemoresistance is a major cause of treatment failure in colorectal cancer (CRC) therapy. In this study, the impact of the IGF2BP family of RNA-binding proteins on CRC chemoresistance was investigated using in silico, in vitro, and in vi
Externí odkaz:
https://doaj.org/article/8de696616f90444eab4aecca58af009f
Autor:
Danielle Welter, Nick Juty, Philippe Rocca-Serra, Fuqi Xu, David Henderson, Wei Gu, Jolanda Strubel, Robert T. Giessmann, Ibrahim Emam, Yojana Gadiya, Tooba Abbassi-Daloii, Ebtisam Alharbi, Alasdair J. G. Gray, Melanie Courtot, Philip Gribbon, Vassilios Ioannidis, Dorothy S. Reilly, Nick Lynch, Jan-Willem Boiten, Venkata Satagopam, Carole Goble, Susanna-Assunta Sansone, Tony Burdett
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-9 (2023)
Abstract The COVID-19 pandemic has highlighted the need for FAIR (Findable, Accessible, Interoperable, and Reusable) data more than any other scientific challenge to date. We developed a flexible, multi-level, domain-agnostic FAIRification framework,
Externí odkaz:
https://doaj.org/article/8abc5ecd6f3c4613a806fc5ab70baccf
Autor:
Philippe Rocca-Serra, Wei Gu, Vassilios Ioannidis, Tooba Abbassi-Daloii, Salvador Capella-Gutierrez, Ishwar Chandramouliswaran, Andrea Splendiani, Tony Burdett, Robert T. Giessmann, David Henderson, Dominique Batista, Ibrahim Emam, Yojana Gadiya, Lucas Giovanni, Egon Willighagen, Chris Evelo, Alasdair J. G. Gray, Philip Gribbon, Nick Juty, Danielle Welter, Karsten Quast, Paul Peeters, Tom Plasterer, Colin Wood, Eelke van der Horst, Dorothy Reilly, Herman van Vlijmen, Serena Scollen, Allyson Lister, Milo Thurston, Ramon Granell, the FAIR Cookbook Contributors, Susanna-Assunta Sansone
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-12 (2023)
Abstract The notion that data should be Findable, Accessible, Interoperable and Reusable, according to the FAIR Principles, has become a global norm for good data stewardship and a prerequisite for reproducibility. Nowadays, FAIR guides data policy a
Externí odkaz:
https://doaj.org/article/ee1aae4367004e42bfdd9ed8a262bd13
Autor:
Jodi M. Carter, Saranya Chumsri, Douglas A. Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W. Hillman, Kathleen S. Tenner, Jennifer M. Kachergus, Heather Ann Brauer, Sarah E. Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A. Leon-Ferre, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Keith L. Knutson, Matthew P. Goetz, Edith A. Perez, E. Aubrey Thompson
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract The utility of spatial immunobiomarker quantitation in prognostication and therapeutic prediction is actively being investigated in triple-negative breast cancer (TNBC). Here, with high-plex quantitative digital spatial profiling, we map and
Externí odkaz:
https://doaj.org/article/d5560e60b96445c4af2242dfe42eae7f
Publikováno v:
Health Expectations, Vol 25, Iss 6, Pp 2700-2708 (2022)
Abstract Background Multimorbidity (the co‐existence of two or more long‐term conditions within an individual) is a complex management challenge, with a very limited evidence base. Theories can help in the design and operationalization of complex
Externí odkaz:
https://doaj.org/article/60df4216cff34ec18599337c2cb8caa8
Autor:
Yojana Gadiya, Vassilios Ioannidis, David Henderson, Philip Gribbon, Philippe Rocca-Serra, Venkata Satagopam, Susanna-Assunta Sansone, Wei Gu
Publikováno v:
Frontiers in Drug Discovery, Vol 3 (2023)
The drug discovery community faces high costs in bringing safe and effective medicines to market, in part due to the rising volume and complexity of data which must be generated during the research and development process. Fully utilising these expen
Externí odkaz:
https://doaj.org/article/7851d8367c8b4406ac6cfd28f4d4d00e